Study Summary
This trial will test if a new device is safe and effective in treating unruptured brain aneurysms.
- Intracranial Aneurysm
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary Ā· 1 Secondary Ā· Reporting Duration: 3 Year Follow-Up
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Surpass Evolve Flow Diverter System
1 of 1
Experimental Treatment
235 Total Participants Ā· 1 Treatment Group
Primary Treatment: Surpass Evolve Flow Diverter System Ā· No Placebo Group Ā· N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ Ā· All Participants Ā· 6 Total Inclusion Criteria
Mark āYesā if the following statements are true for you:About The Reviewer
Michael Gill - B. Sc.
First Published: October 10th, 2021
Last Reviewed: November 10th, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.